Current diagnosis and treatment of migraine;Aktuelle diagnostik und therapie der migräne

Ophthalmologe

Volumn 105, Issue 5, 2008, Pages 501-510

  Diener, H C ^a   Katsarava, Z ^a   Limmroth, V ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b KRANKENHAUS MERHEIM   (Germany)

Author keywords

Chronic migraine; Epidemiology; Headaches; Migraine; Migraine prevention

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANALGESIC AGENT; ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; TRYPTAMINE DERIVATIVE;

ACUPUNCTURE; COMORBIDITY; DRUG COMBINATION; HUMAN; MIGRAINE; PHYTOTHERAPY; REVIEW;

ACUPUNCTURE; ADRENERGIC BETA-ANTAGONISTS; ANALGESICS; ANTICONVULSANTS; CALCIUM CHANNEL BLOCKERS; COMORBIDITY; DRUG THERAPY, COMBINATION; HUMANS; MIGRAINE DISORDERS; NEUROTRANSMITTER AGENTS; PHYTOTHERAPY; TRYPTAMINES;

EID: 44349133531     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-008-1747-6     Document Type: Review

References (20)

1. Bousser M-G (2006) Patent foramen ovale and migraine: evidence for a link? Headache Curr 3: 44-51
2. Brandes JL, Kudrow D, Stark SR et al. (2007) Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA 297: 1443-1454
3. Bussone G, Diener H, Pfeil J et al. (2005) Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Int J Clin Pract 59: 961-968
4. Diener HC, for the ASASUMAMIG Study Group (1999) Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. Cephalalgia 19: 581-588
5. Diener HC, Limmroth V (2004) Medication-overuse headache: a worldwide problem. Lancet Neurol 3: 475-483
6. Diener H, Limmroth V, Fritsche G et al. (2005) Therapie der Migräneattacke und Migräneprophylaxe. Leitlinie der Deutschen Gesellschaft für Neurologie und der Deutschen Migräne- und Kopfschmerzgesellschaft. In: Diener H, für die Kommission Leitlinien der DGN (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie, 3. Aufl. Thieme, Stuttgart New York
7. Diener HC, Kronfeld K, Boewing G et al. (2006) Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol 5: 310-316
8. HT1B/1D agonists) in acute migraine treatment: A meta-analysis of 53 trials. Lancet 358: 1668-1675
9. Fox AW, Chambers CD, Anderson PO et al. (2002) Evidence-based assessment of pregnancy outcome after sumatriptan exposure. Headache 42: 8-15
10. Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia [Suppl 7] 8: 1-93
11. Horton BT, Peters GA (1963) Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases. Headache 3: 214-226
12. Kurth T, Slomke MA, Kase CS et al. (2005) Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 64: 1020-1026
13. Kurth T, Gaziano JM, Cook NR et al. (2006) Migraine and risk of cardiovascular disease in women. JAMA 296: 283-29145
14. Lewis D, Ashwal S, Hershey A et al. (2004) Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 63: 2215-2224
15. Limmroth V, Katsarava Z, Fritsche G et al. (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59: 1011-1014
16. Linde K, Streng A, Jurgens S et al. (2005) Acupuncture for patients with migraine: a randomized controlled trial. JAMA 293: 2118-2125
17. MacGregor EA, Frith A, Ellis J et al. (2006) Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 67: 2159-2163
18. Olesen J, Bousser M-G, Diener H et al. for the International Headache Society (2004) The international classification of headache disorders, 2nd edn. Cephalalgia [Suppl 1] 24: 1-160
19. Olesen J, Diener H, Husstedt IW et al. for the BIBN 4096 BS Clinical Proof of Concept Study Group (2004) Calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS is effective in the treatment of migraine attacks. N Engl J Med 350: 1104-1110
20. Scher AI, Bigal ME, Lipton RB (2005) Comorbidity of migraine. Curr Opin Neurol 18: 305-310